comparemela.com
Home
Live Updates
Hour Urine Protein - Breaking News
Pages:
Hour Urine Protein News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Alnylam Pharmaceuticals, Inc : Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy
-Treatment with Cemdisiran Resulted in a Higher Proportion of Patients Achieving Clinically Meaningful Reductions in 24-Hour Urine Protein to Creatinine Ratio, as Compared to Patients on Placebo -
United kingdom
Christine regan lindenboom
Josh brodsky
Sonalee agarwal
Regeneron pharmaceuticals
Alnylam pharmaceuticals inc
Exchange commission
Alnylam pharmaceuticals
Program leader for the cemdisiran
Cemdisiran resulted
Higher proportion
Hour urine protein
Creatinine ratio
Proteinuria reduction seen
Secondary endpoints
Was generally well tolerated
vimarsana © 2020. All Rights Reserved.